Clinical Trial Results: Ketamine-enhanced Prolonged Exposure Therapy in PTSD [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating ketamine-enhanced prolonged exposure therapy for PTSD has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Post-traumatic Stress Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: VA Office of Research and Development | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2026-07-15